BiochemProbe — Life Science Research Reagents

MT-4129 free base · Synonyms: Lorundrostat

Lorundrostat is an orally active aldosterone synthase inhibitor.

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

MT-4129 structure

CAS No.: 1820940-17-7

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
50 mg USD 480.00 BP-02162-50mg In stock Get quote
100 mg USD 760.00 BP-02162-100mg In stock Get quote
250 mg USD 1,500.00 BP-02162-250mg In stock Get quote
500 mg USD 2,400.00 BP-02162-500mg In stock Get quote
1 g USD 3,800.00 BP-02162-1g In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

Lorundrostat (MT-4129) is an orally active aldosterone synthase inhibitor. Lorundrostat can be used in studies of high blood pressure.

Biological activity

In Vitro Lorundrostat selectively inhibits human CYP11B2 (IC50 = 9 nM), reduces plasma aldosterone and systolic blood pressure, and can be used in research of obesity- or renin-induced hypertension.

Identifiers

SMILES
CC(N[C@@H](CC1)CC[C@H]1NC(CN2CCN(CC2)C3=NN=CC(C4=CC=C(C=C4)C)=N3)=O)=O
InChIKey
YHGVDZULVMINCJ-MEMLXQNLSA-N

Specifications

MW (average)
451.5645
Formula
C24H33N7O2
CAS No.
1820940-17-7
Physical state
Solid
Color
light yellow to yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -20°C, 1 month

Solubility

Soluble in DMSO : 33.33 mg/mL

References

[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
[2]. Laffin LJ, et al. Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial. JAMA. 2023 Sep 26;330(12):1140-1150
[3]. Hideki K, et al., Novel disubstituted 1,2,4-triazine compounds. WO2015163427.

Same research area

Search Cardiovascular Disease